Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol

NCT02592096 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Otitis Media

Interventions

DRUG: 0.1% Pazufloxacin Mesilate Ear Drops
DRUG: 0.3% Pazufloxacin Mesilate Ear Drops
DRUG: 0.5% Pazufloxacin Mesilate Ear Drops
DRUG: Pazufloxacin mesilate injection

Sponsor

Lee's Pharmaceutical Limited